CAVA Group, Inc. operates as a founder-led Mediterranean fast-casual chain focused on build-your-own bowls and pitas with bold, healthful flavors. It runs about 476 restaurants in 29 states plus Washington, D.C., and maintains a packaged dips-and-spreads line sold through grocery channels. The business benefits from solid new-unit productivity, system-wide average unit volumes near $3.1 million, and a loyalty platform that drives nearly 40% of sales. Management aims for at least 1,000 locations by 2032, supported by a debt-free balance sheet and consistent traffic-led comparable sales growth.
From a close of $71.57 on August 19 to $51.64 on September 18, CAVA shares fell approximately 27.9%. The decline was not a straight line; the stock held near post-earnings highs initially before breaking lower in early-to-mid September, with notable selling pressure in the second week of the month. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the broader quarter, the picture is even more pronounced. Starting from a mid-June close near $89, the shares have dropped roughly 42%. They peaked above $90 in early-to-mid June, eased through July, spiked briefly after the August 11 earnings report, and then resumed their downward path. The three-month trend points to a clear de-rating of what had been a high-multiple growth name.
Multiple factors converged to pressure the stock. Profit-taking followed the post-earnings surge in mid-August as investors reassessed valuation. Food-safety concerns added to the headwinds when management noted industry-wide Cyclospora issues linked to fresh produce, even though CAVA does not source the implicated greens or serve iceberg lettuce. Margin pressure also drew attention, with food, beverage, and packaging costs rising 50 basis points to 30% of revenue and labor costs up 30 basis points after a 3% wage investment. Fuel surcharges and the rollout of pre-marinated chicken are expected to keep costs elevated through the rest of fiscal 2026.
Analyst price-target cuts reinforced the valuation reset. Mizuho moved to $70, DA Davidson to $75, Guggenheim to $95, KeyBanc to $95, and JPMorgan lowered its target to $80 on September 18. Trading at a forward price-to-sales multiple above many peers left the stock exposed to multiple compression despite solid operating results.
The quarterly slide reflects a wider re-rating across high-growth restaurant names that had carried premium valuations. CAVA started the period near cycle highs after a strong first half, with upgrades from Morgan Stanley to Overweight in July and UBS to Buy in June. The Q2 report showed revenue of $368.4 million, up 31.3%, and same-restaurant sales up 9% on 5.3% traffic growth, which briefly supported the shares. From what I see, the market shifted focus to forward visibility rather than the headline beat.
Restaurant-level margins contracted 60 basis points to 25.7%, full-year guidance stayed unchanged rather than raised, and the Cyclospora-related sales softness introduced near-term uncertainty. Ongoing concerns around input costs, labor, and a higher third-party delivery mix, combined with a full valuation, sustained selling pressure. Peers such as Chipotle and Shake Shack traded at lower relative multiples during the same stretch.
Attention now turns to whether same-restaurant sales recover fully from the Cyclospora-related softness and whether the 5.3% traffic growth can hold. The Q3 2026 earnings release will provide an important update on comparable-sales trends and any revisions to full-year guidance of 75–77 net new openings, same-restaurant sales growth of 4.5%–6.5%, and adjusted EBITDA of $181–$191 million. Margin trends will remain in focus given the expected cost pressures, while menu additions such as pomegranate glazed salmon and a roasted garlic shrimp test could serve as demand catalysts. Progress toward the 1,000-restaurant target stays central to the longer-term story, alongside broader consumer spending patterns and competitive dynamics in fast-casual dining.
When evaluating data-driven strategies for names like this, I find it helpful to review curated selections of automated tools. Tickeron’s Trending AI Robots page highlights top-performing bots from a larger library covering hundreds of strategies across thousands of tickers. It allows comparison of different approaches by strategy, timeframe, and performance metrics, offering practical context for those interested in rules-based methods without relying on any single signal.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The RSI Oscillator for CAVA moved out of oversold territory on September 21, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 20 of the 24 cases the stock moved higher. This puts the odds of a move higher at 83%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on CAVA as a result. In 43 of 56 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for CAVA just turned positive on September 24, 2026. Looking at past instances where CAVA's MACD turned positive, the stock continued to rise in 21 of 26 cases over the following month. The odds of a continued upward trend are 81%.
Following a +0.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where CAVA advanced for three days, in 157 of 194 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 40 cases where CAVA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for CAVA entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 79 (best 1 - 100 worst), indicating slightly worse than average price growth. CAVA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.163) is normal, around the industry mean (5.328). CAVA has a moderately high P/E Ratio (92.107) as compared to the industry average of (37.793). Projected Growth (PEG Ratio) (4.454) is also within normal values, averaging (7.754). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks. P/S Ratio (4.283) is also within normal values, averaging (2.618).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CAVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Restaurants